Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer

British Journal of Cancer

Volumn 102, Issue 4, 2010, Pages 651-657

  Hamaoka, T ^a,b   Costelloe, C M ^a   Madewell, J E ^a   Liu, P ^a   Berry, D A ^a   Islam, R ^a   Theriault, R L ^a   Hortobagyi, G N ^a   Ueno, N T ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

Bone diseases; Breast neoplasms; Diagnostic imaging; Response assessment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HUMAN; IMAGE ANALYSIS; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PELVIS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RIB; SPINE METASTASIS; TREATMENT RESPONSE; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION;

ADULT; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 76949106055     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605546     Document Type: Article

References (23)

1. Bellamy EA, Nicholas D, Ward M, Coombes RC, Powles TJ, Husband JE (1987) Comparison of computed tomography and conventional radiology in the assessment of treatment response of lytic bony metastases in patients with carcinoma of the breast. Clin Radiol 38: 351-355
2. Citrin DL, Bessent RG, Greig WR (1977) A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 28: 107-117
3. Coleman RE (1991) Assessment of Response to Treatment. Springer Verlag: London
4. Coleman RE, Mashiter G, Whitaker KB, Moss DW, Rubens RD, Fogelman I (1988a) Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 29: 1354-1359
5. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61-66
6. Coleman RE, Rubens RD, Fogelman I (1988b) Reappraisal of the baseline bone scan in breast cancer. J Nucl Med 29: 1045-1049
7. Condon BR, Buchanan R, Garvie NW, Ackery DM, Fleming J, Taylor D, Hawkes D, Goddard BA (1981) Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging. Br J Radiol 54: 18-23
8. Cook GJ, Fogelman I (2000) The role of positron emission tomography in the management of bone metastases. Cancer 88: 2927-2933
9. Du Y, Cullum I, Illidge TM, Ell PJ (2007) Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. J Clin Oncol 25: 3440-3447
10. Even-Sapir E (2005) Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 46: 1356-1367
11. Galasko CS, Doyle FH (1972) The detection of skeletal metastases from mammary cancer. A regional comparison between radiology and scintigraphy. Clin Radiol 23: 295-297
12. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22: 2942-2953
13. Hayward JL, Carbone PP, Heusen JC, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Br J Cancer 35: 292-298
14. Hortobagyi GN (1991) Bone metastases in breast cancer patients. Semin Oncol 18: 11-15
15. Howell A, Mackintosh J, Jones M, Redford J, Wagstaff J, Sellwood RA (1988) The definition of the 'no change' category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast. Eur J Cancer Clin Oncol 24: 1567-1572
16. Israel O, Goldberg A, Nachtigal A, Militianu D, Bar-Shalom R, Keidar Z, Fogelman I (2006) FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy. Eur J Nucl Med Mol Imaging 33: 1280-1284
17. Johnson JR, Williams G, Pazdur R (2003) End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol 21: 1404-1411
18. Libshitz HI, Hortobagyi GN (1981) Radiographic evaluation of therapeutic response in bony metastases of breast cancer. Skeletal Radiol 7: 159-165
19. Rybak LD, Rosenthal DI (2001) Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med 45: 53-64
20. Stafford SE, Gralow JR, Schubert EK, Rinn KJ, Dunnwald LK, Livingston RB, Mankoff DA (2002) Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy. Acad Radiol 9: 913-921
21. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216
22. Tubiana-Hulin M (1991) Incidence, prevalence and distribution of bone metastases. Bone 12(SUPPL. 1): S9-S10
23. World Health Organization (WHO) (1979) WHO Handbook for Reporting Results of Cancer Treatment. World Health Organization Offset Publication: Geneva (Switzerland)